The impact of the SARS-CoV-2 pandemic and the use of face masks on the development of respiratory infections caused by Aspergillus spp., Mucor spp., and Pneumocystis jirovecii within the National Health System of Spain
The COVID-19 pandemic significantly increased the incidence and severity of respiratory fungal infections in Spain, particularly, aspergillosis. Pneumocystosis and mucormycosis also showed moderate increases. CFR increased in all three infections. SARS-CoV-2 co-infection had the greatest clinical impact on aspergillosis, with increased intensive care unit admissions longer hospital stays and increased mortality. Similar trends of increased severity and fatal outcomes were observed in pneumocystosis and mycosis when co-infected with SARS-CoV-2.
Authors
- Moncef Belhassen‐García (ORCID: https://orcid.org/0000-0002-2230-1256)
- Javier Pardo‐Lledías (ORCID: https://orcid.org/0000-0002-4439-7877)
- Raúl Parra Fariñas
- Beatriz Rodríguez Alonso
- Álex García Tellado (ORCID: https://orcid.org/0009-0009-9127-9898)
- Montserrat Alonso‐Sardón (ORCID: https://orcid.org/0000-0003-1829-5858)
- I. IZQUIERDO (ORCID: https://orcid.org/0000-0002-6812-8356)
- Pablo Solís-Sánchez (ORCID: https://orcid.org/0000-0003-4957-4219)
Institutions
- Universidad de Salamanca (ES)
- Complejo Hospitalario de Salamanca (ES)
- Marqués de Valdecilla University Hospital (ES)
- Instituto de Investigación Marqués de Valdecilla (ES)
- Instituto de Investigación Biomédica de Salamanca (ES)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-10-10
- DOI
- https://doi.org/10.1016/j.ijid.2025.108101
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00